Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)(Pisa), and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease

Circulation

Volumn 94, Issue 7, 1996, Pages 1622-1628

  Miccoli, Roberto ^a   Bertolotto, Alessandra ^a   Navalesi, Renzo ^a   Odoguardi, Leonardo ^b   Boni, Andrea ^c   Wessling, Johannes ^d   Funke, Harald ^d   Wiebusch, Heiko ^d   Von Eckardstein, Arnold ^d   Assmann, Gerd ^d  

^a UNIVERSITY OF PISA   (Italy)

^b Ospedale di Lucca   (Italy)

^c Centro Medico Alba   (Italy)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

apolipoproteins; coronary disease; genetics; lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AMINO ACID SUBSTITUTION; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CORNEA OPACITY; CORONARY RISK; DISEASE ASSOCIATION; GENE MUTATION; GENOTYPE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MALE; OBESITY; PHENOTYPE; PRIORITY JOURNAL;

EID: 10144236519     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.7.1622     Document Type: Article

References (36)

1. Gordon D, Rifkind BM. High density lipoproteins: the clinical implications of recent studies. N Engl J Med. 1989;321:1311-1315.
2. Tall AR. Plasmu high density lipoproteins: metabolism and relationship to atherogenesis. J Clin Invest. 1990;86:379-384.
3. Hunt SC, Hasstedt SJ, Kuida H, Stults BM, Hopkins PN, Williams RR. Genetic heritability and common environmental components of resting and stressed Wood pressure, lipids and body mass index in Utah pedigrees and twins. Am J Epidemiol. 1989;129:625-638.
4. Genest JJ Jr, Bard JM, Fruchart JC, Ordovas JM, Schaefer EJ. Familial hypoalphalipoproteinemia in premature coronary artery disease. Arterioscler Thromb. 1993;13:1728-1737.
5. Assmann G, von Eckardstein A, Funke H. High density lipoproteins, reverse transport of cholesterol, and coronary heart disease: insights from mutants. Circulation. 1993;87(suppl III):III-2X-III-34.
6. Breslow JL. Familial disorders of high density lipoprotein metabolism. In: Scriver CR, Beaudet AC Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill Information Services; 1995:2031-2052.
7. Norum KR, Assmann G, Glomset JA. Familial lecithin: cholesterol acyl-transferase deficiency and fish-eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York. NY: McGraw-Hill Information Services; 1995:1933-1951.
8. Assmann G, von Eckardstein A, Brewer HB Jr. Familial high density lipoprotein deficiency: Tangier disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill Information Services; 1995:2053-2072.
9. Serfaty-Lacrosniere C. Civeira F, Lanzberg A, Isaia P, Berg J, Janus ED, Smith MP Jr, Pritchard PH, Frohlich J, Lees RS, Barnard GF, Ordovas JM, Schaefer EJ. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis. 1994;107:85-98.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma without use of a preparative ultracentrifuge. Clin Chem. 1972;18:449-456.
11. Menzel HJ, Boerwinkle E, Schrangl-Will S, Utermann G. Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum Genet. 1988;79:368-372.
12. Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques. 1991;11:298-302.
13. Nofer JR, von Eckardstein A, Wiebush H, Weng W, Funke H, Schulte H, Kohler E, Assmann G. Screening for naturally occurring apolipoprotein A-I variants: apo A-I(ΔK107) is associated with low HDL-cholesterol levels in men but not in women. Hum Genet. 1995;96:177-182.
14. Bruce RA. Methods of exercise testing: step test, bicycle, treadmill, isometrics. Am J Cardiol. 1974;33:715-720.
15. Judkins MP. Selective coronary arteriography: a percutaneous transfemoral technique. Radiology. 1967;89:815-824.
16. Karathanasis SK, Ferris E, Haddad IA. DNA inversion within the apolipoproteins AI/CIII/AIV-encoding gene cluster of certain pa tients with premature atherosclerosis. Proc Natl Acad Sci U S A. 1987;84:7198-7202.
17. Ordovas JM, Cassidy DK, Civeira F, Bisgaier CL, Schaefer EJ. Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J Biol Chem. 1989:264:16339-16342.
18. Matsunaga T, Hiasa Y, Yanagi H, Maeda T, Hattori N, Yamakawa K. Yamaguchi Y, Tanaka I, Obara T, Hamaguchi H. Apolipoprotein A-I deficiency due to a codon nonsense mutation of the apolipoprotein A-Igene. Proc Natl Acad Sci U S A. 1991;88:2793-2797.
19. Ng DS, Leiter LA, Vezina C, Conelly PW, Hegele RA. Apolipoprotein A-I Q(-2)X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia. J Clin Invest. 1994;93:223-229.
20. Lackner KJ, Dieplinger H, Nowicka G, Schmitz G. High density lipoprotein deficiency with xanthomas: a defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene. J clin Invest. 1993;92:2262-2273.
21. Takata K. Saku K, Ohta T, Takata M, Bai H, Jimi S, Liu R. Sato H, Kajiyama G, Arakawa K. A new case of apo A-I deficiency showing codon 8 nonsense mutation of the apo A-I gene without evidence of coronary heart disease. Anterioscler Thromb Vasc Biol. 1995;15:1866-1874.
22. Römling R, von Eckardstein A, Funke H, Motti C, Fragiacomo G, Noseda G, Assmann G. A nonsense mutation in the apolipoprotein A-I gene is associated with high density lipoprotein deficiency but not with coronary heart disease. Arterioscler Thromb. 1994;14:1915-1922.
23. Funke H, von Eckardstein A, Pritchard PH, Karas M, Albers JJ, Assmann G. A frameshift mutation in the apo A-I gene causes corneal opacities, HDL deficiency and partial LCAT deficiency, a syndrome that is distinct from fish eye disease. J Clin Invest. 1991;87:375-380.
24. Gualandiri V, Franceschini G, Sirtori CR, Gianfranceschi G, Orsini GB, Cerrone A, Menotti A. A-I Milano apoprotein identification of the complete kindred and evidence of a dominant genetic transmission. Am J Hum Genet. 1985;37:1083-1097.
25. von Eckardstein A, Funke H, Henke A, Altland K, Benninghoven A, Assmann G. Apolipoprotein A-I variants: naturally occurring substitutions of protine residues affect plasma concentrations of apolipoprotein A-I. J Clin Invest. 1989;84:1722-1730.
26. Iowa associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J Lipid Res. 1992;33:755-763.
27. Bojanovski D, Gregg RE, Zech LA, Meng MS, Bishop C, Ronan R, Brewer HB Jr. In vivo metabolism of proapolipoprotein A-I in Tangier disease. J Clin Invest. 1987;80:1742-1750.
28. Fielding PE, Kawano M, Catapano AL, Zoppo A, Marcovina S, Fielding CJ. Unique epitope of apolipoprotein A-I expressed in preβ-1 high density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry. 1994;33:6981-6985.
29. Luchoomun J, Theret N, Clavey V, Duchateau P, Rosseneu M, Brasseur R, Denefle P, Fruchart JC, Castro GR. Structural domain of apolipoprotein A-I involved in its interaction with cells. Biochim Biophys Acta. 1994;1212:319-326.
30. Sviridov D, Pyle L, Fidege N. Identification of a sequence in apolipoprotein A-I associated with the efflux of intracellular cholesterol to human species and apolipoprotein A-I containing particles. Bio-chemistry. 1996;35:189-196.
31. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill Information Services; 1995:1981-2030.
32. Li H, Reddick RL, Maeda N. Lack of apo A-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler Thromb. 1993;13:1814-1821.
33. Pastzy C, Maeda N, Verstuyft J, Rubin EM. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest. 1994;94:899-903.
34. Rader DJ, Ikewaki K, Duverger N, Feuerstein I. Zech L, Connor W, Brewer HB Jr. Very low high density lipoproteins without coronary atherosclerosis. Lancet. 1993;342:1455-1458.
35. Milano associated with familial hypoalphalipoproteinemia. J Clin Invest. 1993;91:1445-1452.
36. Rader DJ, Ikewaki K, Duverger NJ, Schmidt H, Pritchard H, Frohlich J, Clerc M, Dumon MF, Fairwell T, Zech LA, Santamarina-Fojo SS, Brewer LA. Markedly accelerated catabolisin of apolipoprotein A-II and high density lipoproteins containing apo A-II in classic lecithin:cholesterol acyltransferase deficiency and fish eye disease. J Clin Invest. 1994;93:321-330.